Search

everythinglearnresearchcommunity

for

Search:↓

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Finasteride does not negatively affect male reproductive function.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Dutasteride reduces DHT more effectively than finasteride.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.